Guru Ownership Trend
Guru Analysis for Inhibikase Therapeutics, Inc. (IKT)
Inhibikase Therapeutics, Inc. (IKT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.15 M.
Top institutional holders include Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $505,690.58 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 172.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Inhibikase Therapeutics, Inc. (IKT)
Major holders include Cliff Asness ($950,440). According to the latest reported data, 1 tracked investment managers collectively hold approximately 468,197 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $505,690.58, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited IKT. The total reported sell value was $95,563.
Yes, 0 managers opened new positions in IKT, and 1 increased their existing holdings. The total reported buy value was $601,253.58.